The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 15,000,000 | 10,000,000 | SH | SOLE | 10,000,000 | 0 | 0 | ||
AEGLEA BIOTHERAPEUTICS INC | COM NEW | 00773J202 | 1,424,969 | 116,324 | SH | SOLE | 116,324 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 28,577,700 | 565,000 | SH | SOLE | 565,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 15,171,250 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
AMBRX BIOPHARMA INC | SPONSORED ADS | 02290A102 | 40,463,394 | 3,518,556 | SH | SOLE | 3,518,556 | 0 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 5,325,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 38,441,961 | 2,525,753 | SH | SOLE | 2,525,753 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | 15,484,449 | 1,694,141 | SH | SOLE | 1,694,141 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 19,447,421 | 706,665 | SH | SOLE | 706,665 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 54,268,754 | 5,566,026 | SH | SOLE | 5,566,026 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 14,870,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 9,075,640 | 739,661 | SH | SOLE | 739,661 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 126,054 | 92,687 | SH | SOLE | 92,687 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 39,638,807 | 2,901,816 | SH | SOLE | 2,901,816 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 20,909,500 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 38,390,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 12,768,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,850,360 | 2,244,378 | SH | SOLE | 2,244,378 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 104,413,938 | 4,428,072 | SH | SOLE | 4,428,072 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 38,098,925 | 828,778 | SH | SOLE | 828,778 | 0 | 0 | ||
RAYZEBIO INC | COM | 75525N107 | 6,413,824 | 288,911 | SH | SOLE | 288,911 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 47,569,375 | 2,075,000 | SH | SOLE | 2,075,000 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 26,190,125 | 887,500 | SH | SOLE | 887,500 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 13,903,031 | 957,509 | SH | SOLE | 957,509 | 0 | 0 | ||
THIRD HARMONIC BIO INC | COM | 88427A107 | 10,863,000 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 56,078,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 74,719,500 | 5,450,000 | SH | SOLE | 5,450,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 33,748,000 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 8,253,000 | 1,575,000 | SH | SOLE | 1,575,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 63,025,200 | 1,845,000 | SH | SOLE | 1,845,000 | 0 | 0 |